Liraglutide
Navigation Links
Liraglutide in Medical News
NEW ORLEANS, June 8 /PRNewswire-FirstCall/ -- Novo Nordisk (NVO) data presented at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily liraglutide, taken as monotherapy, leads to statistically significant and sustained reductions in blood sugar and...
... Advantages in Efficacy and Safety Will Make liraglutide the New Clinical Gold Standard Drug by 2011, Acco...n over Hypoglycemia also finds that Novo Nordisk's liraglutide will become the new Decision Resources' proprietar... as surveyed primary care physicians indicate that liraglutide has competitive advantages in terms of efficacy an...
New Diabetes Drug Shows Promise in Trial
... liraglutide mimics effects of a natural hormone, researchers s...hDay News) -- An experimental diabetes drug called liraglutide appears to outperform exenatide (Byetta), the only...ed by liraglutide's maker, Novo Nordisk, shows. liraglutide is a laboratory-made version of glucagon-like pept...... Advantages in Efficacy and Safety Will Make liraglutide the New Clinical Gold Standard Drug by 2011, Acco...n over Hypoglycemia also finds that Novo Nordisk's liraglutide will become the new Decision Resources' proprietar... as surveyed primary care physicians indicate that liraglutide has competitive advantages in terms of efficacy an...
Pipeline for New Obesity Therapies is Focus of New Report
...ylin/Alkermes), exenatide + recombinant leptin (r-metHuLeptin; Amylin/Amgen), Symlin (pramlintide; Amylin), pramlintide + AC162352 (PYY 3-36; Amylin), liraglutide (NN2211; Novo Nordisk), albiglutide (GSK / Human Genome Science), PC-DAC:Exendin-4 (ConjuChem), Boc5 (SH-7871; UC Riverside / Chinese Academy of Scien...Endocrinology Panel Examines Interplay Between Diabetes and Cardiovascular Disease in New Report
... (Amylin), pramlintide + leptin (Amylin/Amgen), Galvus (vildagliptin; Novartis), alogliptin (Takeda), saxagliptin (BMS/AZ), Redona (denagliptin; GSK), liraglutide (Novo Nordisk), Boc5 (UC Riverside / Chinese Acad. Sci.), substituted quinoxalines (Pfizer/Novo Nordisk), Actos (pioglitazone; Takeda/Lilly), Avandia ...Liraglutide in Medical Technology
The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide
NEW ORLEANS, June 8 /PRNewswire/ -- Today, The Lancet published online the results of the Novo Nordisk (NVO) LEAD(TM) 6 study, a direct comparison between two products in a new class of diabetes treatments, the GLP-1 receptor agonists. Results show that patients treated with liraglutide had a...NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- Novo Nordisk (NVO) data presented today at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily liraglutide, taken as monotherapy, leads to statistically significant and sustained reductions in blood sug...
Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
SILVER SPRING, Md., April 2 /PRNewswire-FirstCall/ -- Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) has finalized its discussions of questions related to liraglutide, a once-daily human GLP-1 anal...Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
PRINCETON, N.J., Sept. 25 /PRNewswire/ -- Data from a 52-week phase 3 study (LEADTM 3) of Novo Nordisk's (NYSE: NVO ) liraglutide, a once-daily human GLP-1 analog, were published online today in The Lancet. The study showed that liraglutide, when taken alone, produces statistically significan...ROME, Sept. 8 /PRNewswire-FirstCall/ -- Novo Nordisk (NYSE: NVO ), a global healthcare company, presented data from a phase 3 clinical study (LEAD(TM) 4) today at the 44th annual meeting of the European Association for the Study of Diabetes that demonstrated adding the investigational new dru...
Phase 3 data highlight sustained efficacy and benefits of early treatment with liraglutide versus glimepiride SAN FRANCISCO, June 9 /PRNewswire-FirstCall/ -- Data presented today at the 68th Scientific Sessions of the American Diabetes Association (ADA) demonstrated that once-d...
Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
...esults from the first of five phase 3 studies with liraglutide - the once-daily human GLP-1 analogue. The 26-week...end of the study, more than 50% of patients in the liraglutide group had reached the American Diabetes Associatio...e study, the difference in body weight between the liraglutide and insulin glargine treatment groups was on avera......ted over a period of 14 weeks. Results showed that liraglutide was effective and well tolerated within a wide dos... considerable advance in diabetes treatment." liraglutide acts to lower blood glucose when levels are elevat...domized to receive one of four once-daily doses of liraglutide (0.1, 0.3, 0.6, and 0.9 mg) or placebo. Baseline A...
Liraglutide in Biological Technology
MONTREAL, Oct. 17 /PRNewswire-FirstCall/ -- Today, at the Canadian
Diabetes Association Congress, physicians will get a first-time look at
more detailed results from a phase 3b clinical study (LEAD(TM) 6) comparing
the investigational new drug liraglutide to exenatide. The study showed
that li...
Novo Nordisk Appoints Alan C. Moses as Chief Medical Officer Worldwide
...ice president and chief science officer for Novo Nordisk A/S. "The broadening of Novo Nordisk's diabetes therapeutic portfolio with the development of liraglutide and other novel molecules in the pipeline, and the increasing importance of the U. S. to the Novo Nordisk business, requires a leader with clinical an...Other TagsAtkinAtkinPrescribingReactionsFreezingOther Contentscryingcryingexcessiveexcessiveexcessiveexcessiveexcessiveexcessiveexcessiveexcessiveexciseexciseexciseexciseexerciseexerciseexerciseexerciseexerciseexerciseexerciseexerciseexpectorantemergenciesemergenciesburningburningburningburningextremityextremityextremityextremity
SimonGlucocorticoidAtkinSwordUNESCOPrescribingTriptolidePilatesDiplomatTickingTranscendentalReactionsNonsurgicalFreezing
(Date:11/25/2009)...ady used to fight rheumatoid arthritis, could help... , WEDNESDAY, Nov. 25 (HealthDay News) -- A drug ...rheumatoid arthritis now also shows some promise i...betes. , The drug, rituximab (Rituxan), helped ... even though the disease had destroyed some of the...
(Date:11/25/2009)... plagued by neurological symptoms, study finds ,... Neurological side effects are among the potential...ar cancer who were treated with cisplatin-based ch...included 1,409 Norwegian men treated for unilatera... part in a follow-up survey conducted from 1998 to...
(Date:11/25/2009)...ON,Va.,Nov.25/PRNewswire-USNewswire/--TheAmericanA...areFraudActof2009,"S.2128,whichisdesignedtosubstan...audinMedicare.ThebillwasintroducedbySen.GeorgeLeMi...ovisionstheAmericanAssociationforHomecareoutlinedi...onproposedtoCongressinFebruary.Thoseprovisionsincl...
(Date:11/25/2009)...o treat colorectal cancer also can reverse a rare ...ne therapy for the disease, researchers at Vanderb... Mntrier,s disease causes thickening of the stomac...ng, as well as anemia and swelling in the feet and...ased risk for gastric cancer. Previously, the only...
(Date:11/25/2009)...fs of air on flesh that mimicked parts of speech c...Y, Nov. 25 (HealthDay News) -- People can "hear" n... new research shows. , In fact, sensations on t...actually helped people decipher sounds better, the...en able to show whether we could use tactile infor...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3[1] Type 1 Diabetes May Have a New Foe[0] Long-Term Problems Linked to Testicular Cancer Chemo[1] American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009'[1] Vanderbilt scientists report first effective medical therapy for rare stomach disorder[0] Your Skin Can Help Your Ears Listen
(Date:11/24/2009)...nce is opening new doors to understanding how soun...ring of a marine mammal or if they hear it at all...y scanners that NASA uses to detect flaws in the s...allowing scientists to peek inside the giant head ...-dimensional replicas of a whale,s hearing anatomy...
(Date:11/24/2009)...level action of a remarkable class of ring-shaped ...ith the Lawrence Berkeley National Laboratory (Ber...llography beamline at the Advanced Light Source (A...ne expression and replication, and are vital to th...ectious agents, such as the human papillomavirus, ...
(Date:11/24/2009)...GE Antarctica has long held secrets of the earth,...ntly, there has been very little information on th... of ice for millions of years. Now, a team of rese...e been funded to the tune of $10 million dollars b...to the bottom of things literally. These scientis...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 1Provocative New Fiction Makes for a Fascinating Fast Paced Read 13713 2LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 1LiveProcess Implements Emergency Management Platform with 51 Florida Hospitals 55482 2SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 1SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 2SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 3SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 4SYNAPT G2s Power Versatility and Speed Headlines Comprehensive Portfolio of Mass Spectrometers at IMSC 55479 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |